Trial Details

TERMINATED
Basic Information
Clinical ID c3846
Identifier NCT01442363
Trial Title A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Perianal Crohn's Disease
Interventions DRUG: BLI-1300 low dose|DRUG: BLI-1300 high dose|DRUG: placebo
Participant Information
Sponsor Braintree Laboratories
City Anaheim
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2011-11
Primary Completion Date 2012-10
Completion Date 2012-10